Table 2.

Overall survival and disease-free survival univariate analysis according to clinicopathologic factors in 154 lung cancer patients.

Variable	No. of patients	Percent (%)	6-Year OS rate (%)	P Value	6-Year DFS rate (%)	P Value
Sex
Female	49	31.8%	24.5%	0.007	40.0%	0.003
Male	105	68.2%	42.9%		20.4%
Age
<60	69	44.8%	40.6%	0.398	37.7%	0.523
≥60	85	55.2%	34.1%		30.6%
Smoking status
Never smoke	46	29.9%	28.3%	0.090	26.1%	0.128
Smoke	108	70.1%	40.7%		37.0%
Type of resection
Pneumonectomy	22	14.3%	27.3%	0.067	27.3%	0.139
Lobectomy	127	82.5%	37.8%		33.9%
Bronchial sleeve resection	5	3.2%	60.0%		60%
Lesion
Peripheral	108	70.1%	36.1&	0.584	33.3%	0.456
Central	46	29.9%	39.1%		34.8%
Histologic subtype
Squamous cell carcinoma	100	64.9%	38.0%	0.964	35.0%	0.965
Adenocarcinoma	54	35.1%	35.2%		31.5%
Location of tumour
Left	63	40.9%	34.9%	0.419	28.6%	0.214
Right	91	59.1%	38.5%		37.4%
Stage
I	40	26.0%	65.0%	<0.001	57.5%	<0.001
II	51	33.1%	45.1%		41.2%
IIIA	63	40.9%	12.7%		12.7%
FATS expression
Low	94	61.0%	24.5%	0.001	21.3%	0.001
High	60	39.0%	56.7%		53.3%